EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2

Minela Bećirović iD, Emir Bećirović iD, Emir Begagić iD, Kenana Ljuca iD, Amir Bećirović iD, Denis Mršić, Nadina Ljuca iD, Mugdim Bajrić, Farid Ljuca iD

Medical Sciences · 25.03.2026 · 14 (2) · 163

DOI: 10.3390/medsci14020163 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Medical Sciences, online erschienen am 25.03.2026. Verfasst von Minela Bećirović und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Clinic, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Cardio-Renal Syndrome, Biomarkers, Albuminuria. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cardiorenal syndrome type 2 (CRS-2) is characterized by progressive renal dysfunction caused by chronic heart failure (HF) and is associated with increased morbidity and mortality. However, the prognostic value of renal biomarkers in patients with CRS-2 hospitalized for decompensated HF remains unclear.

Methods

This prospective observational cohort study included 200 consecutive patients hospitalized for decompensated HF in the Intensive Care Unit of the Clinic for Internal Medicine at the University Clinical Centre Tuzla between April and October 2025. CRS-2 was defined as chronic HF with chronic kidney disease persisting for ≥3 months before admission according to KDIGO criteria. Patients were followed for three months. The primary composite outcome was all-cause mortality or initiation of renal replacement therapy.

Results

CRS-2 was identified in 130 patients (65.0%) and was associated with higher in-hospital mortality (32.3% vs. 11.4%, p = 0.002) and three-month mortality (44.6% vs. 21.4%, p = 0.002). Within the CRS-2 subgroup, patients who experienced the primary composite outcome had higher admission levels of cystatin C and urinary albumin-to-creatinine ratio (UACR) and lower estimated glomerular filtration rate (eGFR). ROC analysis demonstrated moderate discriminative ability of cystatin C (AUC 0.739) and UACR (AUC 0.733). In Cox regression analysis, cystatin C (HR 1.534, 95% CI 1.263–1.863, p < 0.001) and UACR (HR 1.003, 95% CI 1.001–1.006, p = 0.001) were significantly associated with the primary composite outcome.

Conclusions

Renal dysfunction markers, particularly cystatin C and albuminuria, are associated with early adverse outcomes in CRS-2 patients hospitalized for decompensated HF. Routine assessment of these biomarkers may provide additional prognostic information and support risk assessment in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardio-Renal SyndromeBiomarkersAlbuminuriaHumansFemaleMalePrognosisAgedProspective StudiesCystatin CGlomerular Filtration RateHeart FailureMiddle AgedHospital Mortality

Stichwörter der Autor:innen

albuminuriacardiorenal syndrome type 2cystatin Cheart failureprognosisrenal biomarkers

Substanzen

BiomarkersCystatin C

Autor:innen und Institutionen

  • Internal Medicine Clinic, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina.
  • Department of Neurosurgery, Cantonal Hospital Zenica, 72000 Zenica, Bosnia and Herzegovina.
  • Department of Gynecology and Obstetrics, University Clinical Center Ljubljana, 1000 Ljubljana, Slovenia.
  • School of Medicine, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina.
  • Clinic for Invasive Cardiology, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina.
  • Department of Physiology, School of Medicine, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina.

ORCID-Profile: Minela Bećirović, Emir Bećirović, Emir Begagić, Kenana Ljuca, Amir Bećirović, Nadina Ljuca, Farid Ljuca

Zitieren

APA

Bećirović, M., Bećirović, E., Begagić, E., Ljuca, K., Bećirović, A., Mršić, D., Ljuca, N., Bajrić, M., & Ljuca, F. (2026). Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2. Medical Sciences, 14(2), 163. https://doi.org/10.3390/medsci14020163

Vancouver

Bećirović M, Bećirović E, Begagić E, Ljuca K, Bećirović A, Mršić D, et al. Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2. Medical Sciences. 2026;14(2):163. doi:10.3390/medsci14020163

BibTeX
@article{Beirovi2026,
  author = {Bećirović, Minela and Bećirović, Emir and Begagić, Emir and Ljuca, Kenana and Bećirović, Amir and Mršić, Denis and Ljuca, Nadina and Bajrić, Mugdim and Ljuca, Farid},
  title = {Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {163},
  doi = {10.3390/medsci14020163}
}
Kostenlos starten →